TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

Levi & Korsinsky Reminds Telix Pharmaceuticals Ltd. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 9, 2026 – TLX

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Levi & Korsinsky, Llp
Levi & Korsinsky Reminds Telix Pharmaceuticals Ltd. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 9, 2026 – TLX

Levi & Korsinsky announces a class action securities lawsuit against Telix Pharmaceuticals Ltd. for alleged securities fraud between February 21, 2025 and August 28, 2025. The complaint alleges the company made false statements about prostate cancer therapeutic progress, overstated supply chain quality, and made misleading statements about business operations. The lead plaintiff deadline is January 9, 2026.

Insights
HBAN   neutral

Being investigated concerning merger with Cadence Bank


TLX   negative

The company is the subject of a securities fraud class action lawsuit alleging material misstatements about prostate cancer therapeutic progress, supply chain quality, and business operations. These allegations indicate potential investor losses and regulatory/legal risks.